Abstract
Introduction: Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an autosomal recessive disorder which results from mutations in the gene encoding immunoglobulin mu binding protein 2 (IGHMBP2). Initial symptoms include intrauterine growth retardation, weak cry and foot deformities. Respiratory distress and progressive muscle weakness with distal lower limb muscle involvement follow usually between the age of 1 to 6 months. Nevertheless, a wide variability in the disease course can be noticed in SMARD1 patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
